SCHEMBL20205612

SCHEMBL20205612

CC1(C)c2cc3c(cc2-c2c1cc(-c1cccc4c1oc1c(-c5ccccc5)cccc14)c1oc4ccccc4c21)C(C)(C)c1cc(-c2cccc4c2oc2c(-c5ccccc5)cccc24)c2oc4ccccc4c2c1-3

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALOX5 P09917 2/20 0.41
▸ CDC14B O60729 2/20 0.37
▸ CDC14A Q9UNH5 2/20 0.37
▸ GGPS1 O95749 1/20 0.36
▸ PRKDC P78527 6/20 0.34
▸ PTGES2 Q9H7Z7 1/20 0.34
▸ PGR P06401 1/20 0.34
▸ SMN1; SMN2 Q16637 3/20 0.33
▸ TP53 P04637 2/20 0.33
▸ CYP3A4 P08684 2/20 0.33
▸ GABRP O00591 1/20 0.33
▸ GABRD O14764 1/20 0.33
▸ NPC1 O15118 1/20 0.33
▸ CA12 O43570 1/20 0.33
▸ TNKS O95271 1/20 0.33
▸ CA1 P00915 1/20 0.33
▸ CA2 P00918 1/20 0.33
▸ ABCB1 P08183 1/20 0.33
▸ PARP1 P09874 1/20 0.33
▸ ADORA3 P0DMS8 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20205391 0.92 ALOX5 (0.41) ALOX5CDC14BCDC14AGGPS1PRKDC
SCHEMBL20205331 0.90 CDC14B (0.38) ALOX5CDC14BCDC14APGRSMN1; SMN2
SCHEMBL20205335 0.89 CDC14B (0.40) ALOX5CDC14BCDC14APGRSMN1; SMN2
SCHEMBL20205471 0.88 CDC14B (0.40) ALOX5CDC14BCDC14APGRSMN1; SMN2
SCHEMBL20205378 0.87 CDC14B (0.38) ALOX5CDC14BCDC14APGRSMN1; SMN2
SCHEMBL20205321 0.86 CDC14B (0.35) ALOX5CDC14BCDC14APGRSMN1; SMN2
SCHEMBL20205469 0.84 MAOA (0.36) ALOX5PGRHPGDKDM4EALDH1A1
SCHEMBL20205320 0.84 CDC14B (0.37) CDC14BCDC14APGRSMN1; SMN2TP53
SCHEMBL20205333 0.84 PLA2G2A (0.36) ALOX5CDC14BCDC14AGGPS1PRKDC
SCHEMBL22859773 0.84 CDC14B (0.38) ALOX5CDC14BCDC14APGRSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11453680-B2 Bisbenzofuran-fused indeno[1,2-B]fluorene derivatives and related compounds as materials for organic electroluminescent devices (OLED) MERCK PATENT GMBH (DE) 2022-09-27 — — US disclosed
EP-3544985-B1 BISBENZOFURAN-FUSED INDENO[1,2-B]FLUORENE DERIVATIVES AND RELATED COMPOUNDS AS MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES (OLED) MERCK PATENT GMBH (DE) 2021-05-12 — — EP disclosed
WO-2018095940-A1 BISBENZOFURAN-FUSED INDENO[1,2-B]FLUORENE DERIVATIVES AND RELATED COMPOUNDS AS MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES (OLED) MERCK PATENT GMBH (DE) 2018-05-31 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11453680-B2 Bisbenzofuran-fused indeno[1,2-B]fluorene derivatives and related compounds as materials for organic electroluminescent devices (OLED) OCIAD2, OCIAD1, JUND ALOX5 354/4885CDC14B 3977/4885CDC14A 4435/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback